Respironics

BioRexis is a biopharmaceutical company that develops and produces biopharmaceuticals.

BioRexis is a biopharmaceutical company. It develops and produces biopharmaceuticals. BioRexis offers protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company’s products include peptide fusion, which is used for the treatment of type 2 diabetes. It also provides biopharmaceutical products for longer-acting interferon and an erythropoietin receptor agonist. The company was founded in 2002 and is based in King of Prussia, Pennsylvania. It operates as a subsidiary of Pfizer.